<DOC>
	<DOC>NCT01478126</DOC>
	<brief_summary>The purpose of this study is to determine whether perioperative glutamine administration possess protective properties on internal organs (heart and gut) in patients with coronary atherosclerosis, operated under cardiopulmonary bypass.</brief_summary>
	<brief_title>Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Adult patients with coronary artery disease operated on under cardiopulmonary bypass Ejection fraction&lt;40% Viral hepatitis Liver cirrhosis Cholecystitis Pancreatitis Chronic severe gastrointestinal disease Surgery on gastrointestinal tract in patient's medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>